Medtech company Baxter International today unveiled the next generation of its airway clearance system, The Vest.
The device is designed to support daily therapy for adults and children with certain chronic lung conditions and retained secretions. It features the same airflow technology as the previous version but now provides enhanced comfort features based on input from clinicians and patients.
“Many patients who are prescribed this therapy use it multiple times a day, every day,” said Jim O’Connell, president of Front Line Care at Baxter. “With that in mind, it was very important for us to design a solution that fits seamlessly into a patient’s daily routine. The Vest APX System offers next-level comfort, ease of use and portability, all while maintaining the performance patients and caregivers have depended on for years.”
Most Read Medical News:
- FDA Approves Glucose Monitor That Can Be Worn for a Year
- Advanced Exoskeleton Cleared to Treat Patients with Spinal Cord Injuries
- An Edible Toothpaste-Based Transistor
- StatLab Begins Manufacturing its Own Slides and Coverglass
The Vest APX System uses High Frequency Chest Wall Oscillation (HFCWO) technology to help dislodge mucus, which can become trapped and lead to lung inflammation and infections, from the bronchial walls. It then mobilizes secretions and mucus from the smaller to larger airways where it can be cleared by coughing or suctioning.
Baxter entered the non-invasive respiratory health industry in December 2021 through its acquisition of Hillrom, which has long been a pioneer in airway clearance. Its HFCWO technology has been demonstrated to be a safe and effective airway clearance solution for nearly 200,000 patients over the past 35 years and has been tested in more than 60 clinical studies to date. In addition to the well-established, patented technology that drives The Vest APX System, the following new features provide an improved overall experience for patients:
- Added comfort: A streamlined, lightweight garment that keeps the abdomen free, a wicking fabric to keep patients cool and a Velcro brand closure for optimal fit.
- Unique designs: Patients have the option to choose from an expanded selection of new garment colors and designs, including vibrant options for adults and playful options for children.
- Easy to use: User-friendly, intuitive navigation on a touch screen that makes it easy for patients and caregivers to start therapy with one button push. The control unit is 19 percent smaller and 30 percent lighter than the previous version and comes with a carrying case.
Patients and care teams also have the option to receive ongoing support with the CARE Connex Program. The program offers touchpoints with Baxter clinical experts throughout the patient care journey to assess and answer questions from patients and caregivers. Baxter received U.S. Food and Drug Administration 510(k) clearance for The Vest APX System earlier this year.
